Abivax SA Cash Flow-to-Debt Ratio
Abivax SA cash flow-to-debt ratio. Abivax SA (ABVX) has a Cash Flow-to-Debt Ratio of -0.43x as of March 2026, meaning its operating cash flow of €-50.52 Million could theoretically repay 0% of its total liabilities (€117.55 Million) in one year. See ABVX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Abivax SA (2013–2025)
Cash flow-to-debt ratio of Abivax SA from 2013 to 2025. Historical debt coverage capacity for Abivax SA across 13 annual periods. Also explore Abivax SA (ABVX) equity growth momentum to track the company's year-over-year net asset growth rate.
Abivax SA Cash Flow-to-Debt Ratio by Year (2013–2025)
Abivax SA cash flow-to-debt ratio by year from 2013 to 2025. Year-by-year debt coverage analysis for Abivax SA. For the full cash flow conversion analysis, see how efficiently does Abivax SA generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.26x | €-162.09 Million | €129.14 Million | ▼ -34.1% |
| 2024 | -0.94x | €-154.07 Million | €164.64 Million | ▼ -26.3% |
| 2023 | -0.74x | €-97.13 Million | €131.05 Million | ▲ +19.2% |
| 2022 | -0.92x | €-65.58 Million | €71.47 Million | ▼ -64.0% |
| 2021 | -0.56x | €-45.66 Million | €81.59 Million | ▼ -25.0% |
| 2020 | -0.45x | €-29.82 Million | €66.62 Million | ▲ +34.9% |
| 2019 | -0.69x | €-27.47 Million | €39.95 Million | ▲ +8.7% |
| 2018 | -0.75x | €-14.60 Million | €19.39 Million | ▲ +49.8% |
| 2017 | -1.50x | €-8.45 Million | €5.63 Million | ▲ +62.7% |
| 2016 | -4.02x | €-15.61 Million | €3.88 Million | ▼ -22.3% |
| 2015 | -3.29x | €-14.90 Million | €4.53 Million | ▼ -301.3% |
| 2014 | -0.82x | €-3.31 Million | €4.03 Million | ▼ -10.2% |
| 2013 | -0.74x | €-3.31 Million | €4.44 Million | — |